Literature DB >> 15814434

Endogenous mechanisms of inhibition of platelet function.

Richard C Jin1, Barbara Voetsch, Joseph Loscalzo.   

Abstract

Platelets play an important role in coagulation, in maintenance of hemostasis, and in the pathophysiology of thrombotic diseases. In response to blood vessel injury, platelets accumulate at the site, recruit other platelets, promote clotting, and form a hemostatic plug to prevent hemorrhage. By contrast, several inhibitory mechanisms modulate platelet function and act in a synergistic manner to prevent pathologic thrombus formation. This review focuses on the principal endogenous inhibitors of platelet function and the central role of the normal endothelium in these inhibitory processes. The main endothelium-derived platelet inhibitors include nitric oxide, prostacyclin, and Ecto-ADPase/CD39/NTPDase. Each of these factors is discussed in turn, and the specific mechanisms by which they inhibit platelet function are reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814434     DOI: 10.1080/10739680590925493

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  23 in total

1.  Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans.

Authors:  Gennady G Yegutkin; Sergei S Samburski; Stefan P Mortensen; Sirpa Jalkanen; José González-Alonso
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

Review 2.  Platelets and von Willebrand factor in atherogenesis.

Authors:  Melinda D Wu; Tamara M Atkinson; Jonathan R Lindner
Journal:  Blood       Date:  2017-02-07       Impact factor: 22.113

Review 3.  Interaction between platelets and endothelium: from pathophysiology to new therapeutic options.

Authors:  Michalis Hamilos; Stylianos Petousis; Fragiskos Parthenakis
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

4.  Acetylcholine Inhibits Platelet Activation.

Authors:  John A Bennett; Sara K Ture; Rachel A Schmidt; Michael A Mastrangelo; Scott J Cameron; Lara E Terry; David I Yule; Craig N Morrell; Charles J Lowenstein
Journal:  J Pharmacol Exp Ther       Date:  2019-02-14       Impact factor: 4.030

5.  Translating from the rivers of Babylon to the coronary bloodstream.

Authors:  Barry S Coller
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

6.  Dipetalodipin, a novel multifunctional salivary lipocalin that inhibits platelet aggregation, vasoconstriction, and angiogenesis through unique binding specificity for TXA2, PGF2alpha, and 15(S)-HETE.

Authors:  Teresa C F Assumpção; Patricia H Alvarenga; José M C Ribeiro; John F Andersen; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

Review 7.  Na(+)/H(+) exchanger in the regulation of platelet activation and paradoxical effects of cariporide.

Authors:  He Benny Chang; Xin Gao; Rachel Nepomuceno; Shaoshan Hu; Dandan Sun
Journal:  Exp Neurol       Date:  2015-01-13       Impact factor: 5.330

8.  Targeted deep sequencing of the PEAR1 locus for platelet aggregation in European and African American families.

Authors:  Ali R Keramati; Lisa R Yanek; Kruthika Iyer; Margaret A Taub; Ingo Ruczinski; Diane M Becker; Lewis C Becker; Nauder Faraday; Rasika A Mathias
Journal:  Platelets       Date:  2018-03-19       Impact factor: 3.862

Review 9.  Pleiotropic effects of intravascular haemolysis on vascular homeostasis.

Authors:  Gregory J Kato; James G Taylor
Journal:  Br J Haematol       Date:  2009-12-01       Impact factor: 6.998

Review 10.  Prostanoids in health and disease.

Authors:  Emer M Smyth; Tilo Grosser; Miao Wang; Ying Yu; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2008-12-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.